• Targeted protein degradation is a transformational modality that continues to move rapidly to the clinic.
• New TPD mechanisms are needed to expand the potential of field even further
• Amphista has pioneered novel mechanisms for inducing proximity to UPS that give:
o Broader cell scope
o Degraders with good druglike properties
o Reduced resistance risk
The European Laboratory Research & Innovation Group
Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Get the App
Get this event information on your mobile by going to the Apple or Google Store and search for 'myEventflo'
